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Objective: Meniscal regeneration was previously shown to be enhanced by injection of mesenchymal
stem/stromal cells (MSCs) but the mode of action of the MSCs was not established. The aim of this study
was to deﬁne how injection of MSCs enhances meniscal regeneration.
Design: A hemi-meniscectomy model in rats was used. Rat-MSCs (rMSCs) or human-MSCs (hMSCs) were
injected into the right knee joint after the surgery, and PBS was injected into the left. The groups were
compared macroscopically and histologically at 2, 4, and 8 weeks. The changes in transcription in both
human and rat genes were assayed by species-speciﬁc microarrays and real-time RT-PCRs.
Results: Although the number of hMSCs decreased with time, hMSCs enhanced meniscal regeneration in
a manner similar to rMSCs. hMSCs injection increased expression of rat type II collagen (rat-Col II), and
inhibited osteoarthritis progression. The small fraction of hMSCs was activated to express high levels of
a series of genes including Indian hedgehog (Ihh), parathyroid hormone-like hormone (PTHLH), and bone
morphogenetic protein 2 (BMP2). The presence of hMSCs triggered the subsequent expression of rat-Col
II. An antagonist of hedgehog signaling inhibited the expression of rat-Col II and an agonist increased
expression of rat-Col II in the absence of hMSCs.
Conclusions: Despite rapid reduction in cell numbers, intra-articular injected hMSCs were activated to
express Ihh, PTHLH, and BMP2 and contributed to meniscal regeneration. The hedgehog signaling was
essential in enhancing the expression of rat-Col II, but several other factors provided by the hMSCs
probably contributed to the repair.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Injuries to the ﬁbrocartilage of the knee meniscus illustrate the
limited ability of human cartilage to repair itself1. For symptomatic
injuries to the meniscus, a meniscectomy is often performed;
a procedure which rapidly leads to osteoarthritis2. Indications for
surgical meniscal repair are limited3, and the results are not always
satisfactory. One potential strategy to enhance meniscal regenera-
tion is to use mesenchymal stem/progenitor cells that can differ-
entiate into cartilage and other skeletal cells4,5. A number of reportso: D.J. Prockop, Institute for
enter College of Medicine at
le, TX 76502, United States.
.J. Prockop).
s Research Society International. Pdemonstrated that healing of the surgically injured meniscus was
enhanced by injection of the adult stem/progenitor cells from bone
marrow referred to as mesenchymal stem or stromal cells
(MSCs)6e8. The observations were initially interpreted on the
assumption that the MSCs repaired the tissue by engrafting and
differentiating into chondrocytes. However, the number of cells
that engrafted was apparently too low to account for the extensive
repair frequently observed9. Similar observations were made with
the use of MSCs in othermodels for human diseases inwhich repair
of tissues was observed without signiﬁcant long term engraftment
of the cells9,10. Therefore, the recent focus has been the repair of
tissues by MSCs through paracrine factors the cells synthesize in
culture9,11 and the additional therapeutic factors they are activated
to express as a result of cross-talk with injured cells and tissues10.
In the present study, we hypothesized that intra-articular
injection of human-MSCs (hMSCs) would enhance meniscal
regeneration in rats after hemi-meniscectomy. We then capitalizedublished by Elsevier Ltd. All rights reserved.
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hMSCs and the endogenous rat cells as the tissue was repaired in
order to deﬁne how intra-articular injection of MSCs enhances
meniscal regeneration.
Materials and methods
Animals
The rat studies were approved by the Institutional Animal Care
and Use Committee of Texas A&M Health Science Center. Twelve-
week-old male Lewis rats (LEW/Crl; Charles River Laboratories;
Wilmington, MA) were used in all experiments with n ¼ 5 in each
group for quantiﬁcation of area and histology, and n ¼ 4 in each
group for RT-PCRs.
Cell preparations
Passage 3 cells were used for all assays. Frozen passage 1 bone
marrow-derived human-MSCs (hMSCs) were obtained from the
Center for the Preparation and Distribution of Adult Stem Cells
(http://medicine.tamhsc.edu/irm/msc-distribution.html), and were
expanded as described previously12. Bonemarrow-derived rat-MSCs
(rMSCs) were isolated from 12-week-old Lewis rats and expanded as
described previously13.
To label the cells for some experiments, CM-DiI (Invitrogen;
Carlsbad, CA) was added at 5 mL/1  106 cells/ml in phosphate
buffered saline (PBS). The cells were incubated for 20min at 37C in
5% humidiﬁed CO2, centrifuged at 480g for 5 min, and washed
twice with PBS.
Meniscectomy and cell injection
Under isoﬂurane anesthesia a hemi-meniscectomy was per-
formed on both knees as described previously7. Immediately after
surgery, 2  106 CM-DiI labeled hMSCs or rMSCs in 50 mL PBS were
injected intra-articularly into the right knee joint. The left knee
joint received 50 mL PBS as the control. The rats were allowed to
walk freely in the cage.
For experiments with cyclopamine, which is an inhibitor of
hedgehog signaling, 2  106 hMSCs were injected postoperatively
on day 0, and cyclopamine (50 mL of 20 mM in 0.1% DMSO/PBS;
SigmaeAldrich) was injected intra-articularly on postoperative
days 0, 1, and 3. Controls were injected with vehicle alone at the
same time points. For experiments with Smoothened agonist (SAG),
we injected SAG solution (50 mL of 100 nM or 500 nM in PBS; Santa
Cruz) intra-articularly on postoperative day 0. We injected
cyclopamine, SAG, or vehicle alone (control) bilaterally into knees
of each rat (n ¼ 4 knees in each group).
Quantiﬁcation of meniscus area
The whole medial meniscus (n ¼ 5 each time point) was
collected at 2, 4, and 8 weeks after injection. The menisci were
photographed and the area measured with Scion image software.
Histology
After photography for areameasurements, menisci were ﬁxed in
4% paraformaldehyde and embedded in parafﬁn. Five mm hori-
zontal sections were cut and stained with Toluidine blue or sub-
jected to immunohistochemistry.
To assess osteoarthritic changes, proximal tibias were dissected
at 2, 4, and 8 weeks after injection and ﬁxed in 4% para-
formaldehyde. They were then decalciﬁed (Decalcifying Solution;Richard-Allan Scientiﬁc; Kalamazoo, MI) at 4C for 14 days and
embedded in parafﬁn. The sections stainedwith Safranin-O and fast
green to visualize the cartilage. Two examiners blinded to treat-
ments scored the sections using the Osteoarthritis Research Society
International (OARSI) osteoarthritic cartilage histopathology
grading system14. The scoring system ranges from 0 to 24, with
0 representing normal and 24 representing the most severe
osteoarthritis.
Immunohistochemistry
Rat type II collagen was visualized using diaminobenzidine
(DAB) staining of a mouse monoclonal antibody (clone II-4C11)
from MP Biomedicals. For immunoﬂuorescence, primary anti-
bodies to Indian hedgehog (Ihh) (ab52919), bone morphogenetic
protein 2 (BMP2) (ab6285), parathyroid hormone-like hormone
(PTHLH) (ab55631), and parathyroid hormone receptor 1 (PTH-R1)
(ab75150) were obtained from Abcam. Species-speciﬁc AlexFluor-
488 conjugated secondary antibodies were from Invitrogen.
Real-time RT-PCR analysis for selected mRNAs
RNAwas isolated from regenerated menisci using RNA Bee (Tel-
Test; Friendswood, TX) according to manufacturer’s instructions
and cleaned by RNeasy Mini Kit (QIAGEN; Valencia, CA). Total RNA
was used in one-step real-time RT-PCR (ABI 7900 Sequence
Detector, Applied Biosystems; Foster City, CA) using QuantiTect
Probe RT-PCR Kit (QIAGEN). Reactions were incubated at 50C for
30 min, 95C for 15 min, then 40 cycles at 95C for 15 s followed by
60C for 1 min.
For normalization of gene expression, human-speciﬁc GAPDH
primers and probe (TaqMan Gene Expression Assays ID,
Hs99999905_m1), rat-speciﬁc GAPDH primers and probe (TaqMan
Gene Expression Assays ID, Rn01775763_g1), or 18S rRNA primers
and probe (TaqMan Gene Expression Assays, ID Hs03003631_g1)
were used as internal controls (all from Applied Biosystems;
Supplemental Table 3). All primers were tested for species-
speciﬁcity; the values for critical threshold were indistinguishable
from background with RNA from the alternative species.
Statistical analysis
For comparison of two groups, the ManneWhitney U test was
used. For multiple comparisons of three groups or more than three
groups, one-way ANOVA followed by Bonferroni’s post hoc test was
used. P values less than 0.05 were considered to be statistically
signiﬁcant. Data were analyzed using StatView software.
Additional methods
Detailed methods for cell culture, surgical procedures, immuno-
histochemistry and microarrays are described in the Supplemental
Methods.
Results
Intra-articular injection of hMSCs promoted meniscal regeneration
and inhibited development of osteoarthritis
To determine whether intra-articular injection of hMSCs would
enhance regeneration of rat meniscus, we performed hemi-
meniscectomy7 in both knees of wild-type Lewis rats. We then
closed the knee joint and immediately injected CM-DiI labeled
hMSCs (2  106 cells in 50 mL PBS) into the right knee joint and an
equal volume of PBS into the left knee. For positive controls for the
M. Horie et al. / Osteoarthritis and Cartilage 20 (2012) 1197e1207 1199xenotransplantation, we repeated the experiments with the same
number of rMSCs. At 2 and 4 weeks, injection of the hMSCs
enhanced regeneration as indicated by the morphology of the
meniscus [Fig. 1(A)] and the size of regenerated area [Fig. 1(B)]. At 8
weeks the beneﬁcial effects of the hMSCs were apparent inFig. 1. Intra-articular injection of hMSC promoted regeneration of rat meniscus and inhibited
ﬁndings of the meniscus 2, 4, and 8 weeks after the injection of PBS (left), hMSCs (middle), o
(B) Area of the total meniscus injected with PBS, hMSCs, or rMSCs at 2, 4, and 8 weeks. The
Bonferroni post-tests. P values less than 0.017 were considered to be statistically signiﬁca
middle), and immunostained for type II collagen (bottom) after PBS or hMSCs injection. The
type II collagen. The schema of the meniscus on the left is shown for orientation. Symbols: N
Scale bar, 100 mm. (D) Representative gross photographs (top) and sections (bottom) of the j
ﬁbrillation and erosion. The white circle indicates the medial tibial plateau. The tibia was se
Scale bars, 2 mm (top) or 200 mm (bottom). (E) Quantiﬁcation of histological analysis using t
lower and upper limit of 95% CI; n ¼ 5 for each group (ManneWhitney U test).histological sections stainedwith Toluidine blue for metachromasia
or labeled with antibodies to type II collagen [Fig. 1(C)]. At 8 weeks
the absolute area of regeneration was not signiﬁcantly different
between PBS and hMSC menisci because of the innate ability of rat
meniscus to regenerate itself [Fig. 1(B)]. Of special note was thatdevelopment of osteoarthritis after the meniscectomy. (A) Representative macroscopic
r rMSCs (right). The white dotted line indicates the regenerated tissue. Scale bar, 1 mm.
horizontal lines are mean values; n ¼ 5 for each group (one-way ANOVA followed by
nt). (C) Representative sections of the meniscus stained with Toluidine blue (top and
staining in the PBS-treated sample was less with Toluidine blue and the antibody for
, native meniscus; R, regenerated meniscus; TB, Toluidine blue; Col II, type II collagen.
oint surface of the tibia at 8 weeks. The cartilage was stained with India ink to identify
ctioned coronally and stained with safranin-O and fast green to identify cartilage (red).
he OARSI cartilage osteoarthritis histopathology grading system. Values are mean with
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transplantation of hMSCs and syngeneic transplantation of rMSCs
to enhance regeneration [Fig. 1(B)].
We next evaluated articular cartilage damage in adjacent
femoral and tibial articular surfaces. Both articular surfaces had
osteoarthritic change but they were more severe on the medial
tibial plateau than on themedial femoral condyle (data not shown).
Therefore, we quantiﬁed the osteoarthritic change in the tibial
plateau. At 8 weeks after the meniscectomy, severe degenerative
changes were observed in the medial tibial plateau in PBS knees,
but hMSCs inhibited the osteoarthritis progression after menis-
cectomy [Fig. 1(D and E)].
Detection of the injected hMSCs
CM-DiI þ hMSCs were readily detected in histological sections
of the regenerated meniscus but it was apparent that they
decreased rapidly in number with time (Supplemental Fig. 1). The
labeled cells seen at 2 and 4 weeks had the morphology of ﬁbro-
blasts but the small number of CM-Dil-labeled cells seen at 8 weeks
had the more spherical morphology of chondrocytes
(Supplemental Fig. 1). We conﬁrmed the persistence of the hMSCs
by labeling the sections with human-speciﬁc nuclear antibody
(Supplemental Fig. 2). For a quantitative measure of the engrafted
human cells15,16, we prepared standard curves by adding pre-
determined numbers of hMSCs to the surgically injured menisci
just before homogenization, extracted RNA, and assayed it with
a quantitative RT-PCR assay speciﬁc for human GAPDH
[Supplemental Fig. 3(AeC)]. Approximately 2% of hMSCs injected
into the synovial space were recovered in the regenerating tissue at
day 1, and 1% of hMSCs were recovered at day 3. No hMSCs were
detected at day 7 with the assay with the RT-PCR for human GAPDH
[Supplemental Fig. 3(B)]. The standard curve [Supplemental
Fig. 3(A)] suggested that the assay was sensitive to the detection
of 200e1000 hMSCs. However, hMSCs were still detected by
immunohistochemistry at 8 weeks (below). The discrepancy is
probably explained by the standard curve over-estimating the
sensitivity of the assay, since it was generated by simply adding
hMSCs to the tissue before extraction of the RNA; efﬁcient extrac-
tion of RNA from a cartilaginous tissue such as the meniscus that is
rich in proteoglycans usually requires digestion of the matrix and
isolation of the cells17. Therefore the real-time RT-PCR assay
reﬂected the rapid decrease in hMSCs in the ﬁrst few days after
administration but probably under-estimated the cells remaining
in the tissue at later times.
The injected hMSCs were activated to express Ihh, PTHLH, and BMP2
The use of a xenotransplantation made it possible to follow
simultaneously changes in both the donor hMSCs and the endoge-
nous rat cells in the regeneratingmeniscus. A total of 2106 hMSCs
were injected into the hemi-meniscectomized knee joint of rat, and
RNA was extracted from the meniscus 3 days after the injection,
a time at which assays for human GAPDH mRNA indicated there
were adequate amounts of human mRNA for analyses. As we
observed previously15,18, an initial impression of the potential cross-
talk between the hMSCs and host rodent cells can be obtained by
assaying the same RNA on species-speciﬁc microarrays.
Therefore, the same samples of RNA were assayed on human
microarrays and on rat microarrays, and the data were ﬁltered for
cross-hybridization (see Supplemental Methods). The data
(Supplemental Table 1) indicated that the human transcriptome
was changed with up-regulation of 93 human transcripts. Also, the
data suggested that a series of human genes were down-regulated,
but the number could not be accurately deﬁned because signals formany human genes were eliminated from the analysis by ﬁltering
for cross-hybridization in the samples which contained a low ratio
of human RNA to rat RNA.
The 40 most highly up-regulated human transcripts
(Supplemental Table 1) were subjectively examined for candidate
genes of interest, and human-speciﬁc real-time RT-PCR assays were
used to conﬁrm the microarray data [Fig. 2(A)]. Because adminis-
tration of hMSCs enhanced regeneration of themeniscus,weelected
to focus on the genes related to growth factors, such as PDGF, VEGF,
FGF, TGF-b, BMP2 and PTHLH. As observed previously19, the RT-PCR
assays indicated that the increase in expression of some of the genes
was larger than the values obtained from the microarrays. On day 3
the increase in PTHLH was 443-fold and the increase in BMP2 was
194-fold. Themicroarray data did not reveal any changes in Ihh, but
Ihh was observed to up-regulate BMP2 and PTHLH during the
endochondral ossiﬁcation20,21. Therefore we assayed for Ihh
expression. Surprisingly, human Ihh was also increased 22-fold at
day 3 compared to control hMSCs. Expression of human Ihh not
detected onday7, apparently because only a small numberof hMSCs
remained in the tissue [Supplemental Fig. 3(B)].
We next examined the time sequence of changes in the human
transcriptome [Fig. 2(B)]. The gene expression of human PTHLH
increased 516-fold as early as day 1. The level per human cell
(normalized by DCt for speciﬁc for human GAPDH) increased
further between day 3 and day 7 (data not shown), but because the
RNAs we have isolated included both human and rat RNAs and the
number of human cells was rapidly decreasing, the total level of
transcript were normalized again by 18S rRNA, which contains
sequences that are 100% conserved among all the eukaryotes. The
total level of transcript of PTHLH (normalized by DCt for eukaryotic
18S rRNA) was lower on day 7 [Fig. 2(B)]. BMP2 also increased 663-
fold at day 1, and further increased at day 7 if expressed on a per
human cell basis but not as total tissue content (data not shown).
Immunohistochemistry conﬁrmed that the injected hMSCs that
adhered to the injured site expressed Ihh, PTHLH, and BMP2
[Fig. 2(CeE)].
hMSCs up-regulated expression of chondrogenic genes in rat cells
The data from the rat microarrays indicated that there was up-
regulation of expression of 91 rat genes and down regulation of
42 rat genes by a factor of 2-fold or more. The most highly up-
regulated 40 rat genes are shown in Supplemental Table 2.
Assays by rat-speciﬁc real-time RT-PCR were carried out for
transcripts of genes expressed during chondrogenesis. Injection of
the hMSCs increased the levels of Sox9 mRNA at day 3 and day 7
(Fig. 3). As expected from the assays by immunohistochemistry [see
Fig. 1(C)], injection of the hMSCs increased expression of the rat
Col2a1 gene at day 7 and 14. The increases in several other rat genes
were more variable. There was no consistent effect of the hMSCs on
expression of rat Ihh, or the rat BMP receptor BMPR1A. However,
hMSC injection increased the expression of rat receptor for PTHLH
(PTH-R1) and BMP2 on day 3, and PTHLH on day 14. The increased
expression of PTHLH and PTH-R1 was evaluated by immunohisto-
chemistry (Fig. 4). Interestingly, not only human (CM-DiI positive)
cells but also rat (CM-DiI negative) cells surrounding hMSCs
expressed PTHLH and PTH-R1 at day 7.
The role of human Ihh
We elected to test the hypothesis that activation of hMSCs to
express Ihh was an essential step in enhancing the regeneration of
the rat meniscus. To test the hypothesis, we used cyclopamine,
a steroid alkaloid that inhibits Ihh signaling by serving as an
antagonist to the downstream target Smoothened. We elected to
Fig. 2. Intra-articular injected hMSCs were activated to express Ihh, PTHLH, and BMP2. (A) Real-time RT-PCR for human-speciﬁc mRNA in regenerated meniscus 3 days after
injection. Values are meanwith lower and upper limit of 95% CI of fold increase over Con, normalized by DDCt for human-speciﬁc GAPDH; n ¼ 4. Symbols: Con, 20,000 hMSCs added
to injured meniscus from PBS injected knee before RNA extraction; IA day 3, regenerated meniscus 3 days after intra-articular (IA) injection of hMSCs. (B) Time sequence of human
gene expression by real-time RT-PCR for human PTHLH, BMP2, and Ihh in regenerated meniscus. Values are meanwith lower and upper limit of 95% CI of the relative quantities (RQ)
normalized to 18S rRNA reﬂecting total levels of both human and rat transcripts. (CeE) Immunohistochemistry of anti-human/rat Ihh (C), PTHLH (D), or BMP2 (E) 3 or 7 days after
hMSC injection. Primary antibodies for Ihh and PTHLH reacting with both human and rat were used. Low magniﬁcation (top) and higher magniﬁcation (bottom) of regenerated
meniscus. Right column: merged images (CM-DiI, red; Ihh/PTHLH/BMP2, green; DAPI, blue). The white dotted line indicates border between native and regenerated meniscus, and
the white solid line indicates outer edge of regenerated meniscus. CM-DiI labeled hMSCs (red) expressed Ihh, PTHLH, and BMP2 (green) (arrows in merge). Note: CM-DiI negative
rat-derived cells surrounding hMSCs also expressed Ihh and PTHLH (arrowhead in merge) at day 7. The schema of the meniscus on the top left (C) is shown for orientation. Symbols:
N, native meniscus; R, regenerated meniscus. Scale bars, 50 mm.
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only 4 h after ip or po administration22 and a similar dosage
schedule was used previously in experiments on repair of a cranial
defect23. In the presence of cyclopamine, hMSCs did not enhance
expression of rat Col2a1 [Fig. 5(A)]. Therefore the results were
consistent with the hypothesis that expression of Ihh was essential.
As expected, administration of cyclopamine also decreased
expression of Patched (Ptc1) and Gli1, downstream targets of
hedgehog signaling [Fig. 5(B and C)]. However, cyclopamine did not
inhibit morphological regeneration of the meniscus as ﬁbrous
tissue [Fig. 5(D and E)]. As a further test of the hypothesis we usedSAG, a Smoothened agonist of hedgehog signaling. We elected to
inject SAG on day 0 because expression of human Ihh reached
a peak on day 1 and then declined [Fig. 2(B)].
Injection of SAG after the meniscal surgery enhanced expres-
sion of rat Ptc1, Gli1, and Col2a1 gene in the absence of hMSCs
[Fig. 5(AeC)]. However, injection of SAG did not increase the area
of repair [Fig. 5(D and E)]. The results suggested that expression of
Ihh by the hMSCs was essential for enhancing the rat-Col II
expression but probably not in itself sufﬁcient for the enhanced
regeneration observed with administration of hMSCs in the model
(Supplemental Fig. 4).
Fig. 3. hMSCs up-regulated expression of chondrogenic genes in rat cells. Real-time RT-PCR assay for rat-speciﬁc mRNA (Sox9, Col2a1, Ihh, PTHLH, PTH-R1, BMP2, and BMPR1A) in
the regenerated meniscus 3, 7 and 14 days after PBS or hMSC injection. Values are meanwith lower and upper limit of 95% CI of the RQs normalized to rat-speciﬁc GAPDH; n ¼ 4 for
each group. *P < 0.001 (ManneWhitney U test).
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As reported previously6e8, injection of MSCs enhanced the
regeneration of surgically injured meniscus. Of special interest was
the observation here that xenotransplantation of hMSCs was as
effective as syngeneic rMSCs in repairing the rat meniscus7. The
effectiveness of the hMSCs in the immunocompetent rats is
consistent with previous reports that MSCs were immune priv-
ileged24e26 and that hMSCs had about the same half-life after
injection into the hippocampus of wild-type mice as after injection
into the hippocampus of immunodeﬁcient mice18. The hMSCs
promoted both the synthesis of rat type II collagen in the regen-
erating meniscus and apparently the resilience of the tissue since
they reduced the tibial osteoarthritis that developed in control
knees. The hMSCs employed here may have been particularly
effective because they were prepared with a standardized protocol
that generates cultures enriched for early progenitor cells12,27,28.
We previously evaluated the fate of rMSCs by in vivo imaging
and histology in the same rat hemi-meniscectomy model7. In vivo
imaging analysis demonstrated that more than 1000 of intra-
articular injected rMSCs were detected in the knee joints for 28
days. The number of intra-articular injected LacZþ rat cells were
also decreased with time, but small number of LacZþ cells were
observed in the regenerated meniscus up to 12 weeks. In the
present study, we did not directly compare the number of injected
cells in rMSCs vs hMCSs; however apparently the rat cells survived
somewhat longer than human cells7.
The use of xenotransplantation of hMSCs made it possible to use
species-speciﬁc assays obtain an initial impression of cross-talkbetween the hMSCs and the host cells in the meniscus15,18 Real-
time RT-PCR assays of mRNA for human-speciﬁc GAPDH demon-
strated that only a small number of the hMSCs injected into the
synovial space engrafted to the regenerating edge of the meniscus.
The cells disappeared rapidly but immunohistochemistry of the
tissue demonstrated that a small number were detectable at 8
weeks. Microarray data demonstrated that shortly after the hMSCs
had engrafted, there were marked changes in their transcriptomes
with up-regulation of 93 human genes. Therefore, exposure of the
hMSCs to the in vivo microenvironment had a major effect on
the human cells. Real-time RT-PCR assays to conﬁrm some of the
microarray data demonstrated several hundred fold increases in
the levels of transcripts for the cartilage characteristic genes PTHLH
and BMP2. These increases were accompanied by increases in the
expression of human Ihh.
The time course for changes in the transcriptomes of the human
cells and the rat cells in the regenerating edge of the meniscus
suggested that the activation of the human cells to express Ihh,
PTHLH and BMP2 promoted the subsequent expression of the
Col2a1 gene by the rat cells (Fig. 6). The results indicated that the
expression of Ihh was critical since an inhibitor of hedgehog
signaling negated the effects of hMSCs in promoting expression of
the rat Col2a1 gene. The inhibitor was not species-speciﬁc and
therefore inhibited expression of both human and rat Ihh. Unfor-
tunately, several experiments to use siRNAs to knock down the Ihh
transcripts in the hMSCs under the conditions used previously15
were unsuccessful: the transcripts were knocked down with the
negative controls with the scrambled siRNA controls to the same
extent as with the speciﬁc siRNAs. However, the conclusion that
Fig. 4. A large number of PTHLH/PTH-R1 positive cells were found in the regenerated tissue after injection of hMSCs. (AeD) Immunohistochemistry of anti-human/rat PTHLH (A, B)
or PTH-R1 (C, D) 7 days after the injection of PBS (A, C) or hMSCs (B, D). Low magniﬁcation images are shown in the left and higher magniﬁcation of the regenerated tissue is shown
in the right. Staining of nuclei (DAPI, blue), CM-DiI (red), and PTHLH or PTH-R1 (green) is shown. The white dotted line indicates the border between the native meniscus and
regenerated tissue, and the white solid line indicates the outer edge of the regenerated tissue. A large number of PTHLH or PTH-R1 positive cells (green) were observed in the
regenerated meniscus after the injection of hMSCs (B, D). In contrast, few PTHLH or PTH-R1 positive cells were present in the PBS injection group (B, D). Note that not only CM-DiI
positive human cells (arrows in merge) but also CM-DiI negative rat cells (arrowheads) expressed PTHLH or PTH-R1.
M. Horie et al. / Osteoarthritis and Cartilage 20 (2012) 1197e1207 1203
Fig. 5. Effects of an inhibitor and an agonist of hedgehog signaling. (A) Real-time RT-PCR assay for rat-speciﬁc Col2a1 mRNA. RNA was recovered from the regenerated meniscus 2
weeks after the various treatments, including injection of PBS, hMSCs, hMSCs plus 0.1% DMSO (as a control of cyclopamine), hMSCs plus cyclopamine (50 mL of a 20 mM in 0.1%
DMSO), 100 nM or 500 nM Smoothened agonist (SAG). Values are mean with lower and upper limit of 95% CI of the RQs normalized to rat-speciﬁc GAPDH; n ¼ 4 for each
group. þP ¼ 0.005, þþP ¼ 0.002 (one-way ANOVA followed by Bonferroni post-tests. P values less than 0.0033 were considered to be statistically signiﬁcant). (B, C) Real-time RT-
PCR assay for rat-speciﬁc Ptc1 (B) and Gli1 (C), downstream targets of hedgehog signaling. RNA was recovered from the regenerated meniscus 3 days after the various treatments.
Values are meanwith lower and upper limit of 95% CI of the RQs normalized to rat-speciﬁc GAPDH; n ¼ 4 for each group. þP ¼ 0.004, þþP ¼ 0.002 in B, þþP ¼ 0.002, þþþP ¼ 0.001
in C (one-way ANOVA followed by Bonferroni post-tests. P values less than 0.005 were considered to be statistically signiﬁcant). (D) Representative macroscopic photographs of the
meniscus 2 weeks after the various treatments. Scale bar: 1 mm. (E) Area of the total meniscus 2 weeks after the various treatments. Values are mean with lower and upper limit of
95% CI; n ¼ 4 for each group (one-way ANOVA followed by Bonferroni post-tests. P values less than 0.0083 were considered to be statistically signiﬁcant).
M. Horie et al. / Osteoarthritis and Cartilage 20 (2012) 1197e12071204expression of Ihh by the hMSCs played a critical role was supported
by the observation that an agonist of hedgehog signaling prompted
expression of the rat Col2a1 gene in the absence of hMSCs.
The agonist of hedgehog signaling did not however fully
duplicate the effects of the hMSCs because it did not enhance
restoration of the morphology of the meniscus. Therefore the
hMSCs made additional contributions to the regeneration process
that probably involved the expression of human PTHLH, BMP2, and
perhaps other factors.
The increased expression of the Col2a1 produced by the agonist
of hedgehog signaling raises the possibility that such agonists
might provide a therapy for improving cartilage repair. However,
the effects of hedgehog signaling are highly dependent on
context29. Lin et al.30 demonstrated that hedgehog signaling was
increased in human osteoarthritic samples and in mice with
surgically induced osteoarthritis. Also, transgenic mice over-
expressing hedgehog were more predisposed to osteoarthritis
than wild-type mice. In addition, they observed that pharmaco-
logical and genetic inhibition of hedgehog signaling decreased the
development of osteoarthritis. Experiments within culturedchondrocytes were consistent with these observations. The reasons
for the dramatic differences from the observations made here are
not apparent. The data however suggest that the relatively brief
increase in hedgehog signaling we observed after a single admin-
istration of hMSCs immediately after hemi-meniscectomy
enhanced a process of orderly chondrogenesis much as occurs
during normal development of the skeleton. In contrast, the more
chronic increases in hedgehog signaling that Lin et al.26 examined
in the setting of the extensive tissue destruction seen in osteoar-
thritis apparently drive a disordered hypertrophy of chondrocytes
that exacerbates the pathological changes. One consequence of
these observations is that agonists of hedgehog signaling may
improve meniscal regeneration and chondrogenesis after acute
injuries, but chronic administration of the same agents may
increase the severity of osteoarthritis30.
The results are consistent with previous observations withMSCs
in that increases in expression of Ihh and PTHLH were seen during
chondrogenic differentiation of MSCs in vitro31,32. The results are
also consistent with previous observations on the roles of Ihh,
PTHLH and BMP2 in chondrogenesis. Ihh is one of the master
Fig. 6. Possible mechanism of rat meniscal regeneration by intra-articular injection of
hMSCs. (A) Summary graph of time sequence of human and rat gene expression
changes by species-speciﬁc real-time RT-PCR. Intra-articular injected hMSCs were
activated to express human Ihh, PTHLH, and BMP2 (red) as early as day 1. Values for
human genes are expressed as fold increase over values for controls (Con) of cultured
hMSCs, normalized by DDCt for 18S to reﬂect total levels of both human and rat
transcripts. Rat Col2a1 gene expression in the regenerated meniscus was increased
after the injection of hMSCs (blue). Values for rat genes are expressed as fold increase
over values for PBS day 3, normalized by DDCt for rat GAPDH. Values are means from
RT-PCR data presented in Figs. 2(B) and 3. Symbols: Con, 20,000 hMSCs added to
injured meniscus from PBS injected knee before RNA extraction. (B) Summary diagram
of the possible mechanism for rat meniscal regeneration by hMSCs. (1) Intra-articular
injected hMSCs were activated to express Ihh, PTHLH, and BMP2 when they were
exposed to the in vivo microenvironment. (2) Human Ihh expressed by the hMSCs
enhanced expression of rat Col2a1 gene probably through the downstream hedgehog
target of rat Gli1 and then through Sox9. hMSCs did not enhance expression of rat Gli1
and Col2a1 in the presence of cyclopamine. In contrast, injection of Smoothened
agonist enhanced expression of rat Gli1 and Col2a1. (3) PTHLH and BMP2 may also
have enhanced expression of rat Col2a1 through rat Sox9. Symbols: X-factors,
unknown factors which activate hMSCs to express Ihh, PTHLH, and BMP2.
M. Horie et al. / Osteoarthritis and Cartilage 20 (2012) 1197e1207 1205regulators of both chondrocyte and osteoblast differentiation
during endochondral bone formation. Ihh is expressed in mesen-
chymal cells at the early stage of pre-chondrocytes and the late
stage of pre-hypertrophic chondrocytes33. Ihh stimulates chon-
drocyte proliferation directly and, through stimulation of PTHLH
synthesis, determines the distance from the end of the bone at
which chondrocytes stop proliferating and undergo hypertrophic
differentiation34. The results are also consistent with previous
observations that Gli, a downstream target of hedgehog signaling,
can up-regulate Sox9 by binding to its promoter35,36. During
endochondral ossiﬁcation, PTHLH is synthesized by chondrocytes
and perichondrial cells at the ends of the developing bones. It
stimulates the proliferation of chondrocytes and suppresses their
terminal differentiation31,37,38. PTHLH up-regulates Sox9 tran-
scription39, which has been shown to promote the differentiation of
mesenchymal cells into chondroblasts40. Thus, PTHLH may have
acted upon the endogenous rat mesenchymal cells and induced
their differentiation through the Sox9 pathway. In addition, PTHLH
up-regulates the expression of Bcl2, an apoptosis inhibitor41, which
also may have a role in regulating rat matrix production42. BMP
signaling has been shown to play an important role in the devel-
opment of bone and cartilage. BMP2 has been demonstrated to be
a potent stimulator of chondrocyte metabolism and differentiation
in vitro43e45 and in vivo46,47. For example, BMP2 stimulated DNA
synthesis of bovine meniscal cells in vitro in a dose-dependent
manner48. In addition, Ihh is a direct target gene of BMP249, andIhh promotes BMP expression. In the injured meniscus, BMP2
produced by hMSCs may have stimulated endogenous rat mesen-
chymal cells to proliferate and differentiate. It may also have acti-
vated Ihh signaling in human and rat cells.
In effect, the observations presented here demonstrated that
the hMSCs that engrafted in the knee joint of the hemi-
meniscectomized rat were activated by the microenvironment of
the injured meniscus to express extremely high levels of three
genes that play critical roles in the development of normal carti-
lage: Ihh, PTHLH and BMP2. The human cells rapidly decreased in
number but their presence triggered the subsequent expression of
type II collagen by the rat meniscal cells. The expression of human
Ihh was essential for up-regulating rat genes for type II collagen,
Patched, and Gli1, an observation that raised the possibility that
agonist of Ihh signaling may be useful in treating acute injuries to
the meniscus and perhaps articular cartilage. However, for clinical
application, interspecies differences have to be considered. The
inherent healing capacity of the human meniscus has been shown
to be lacking in the inner third and is very limited in the middle
third50. We used a rat model, and rat meniscus has a greater
spontaneous healing potential7. To demonstrate the effectiveness of
agonist of Ihh signaling for meniscus regeneration, further experi-
mental studies in larger animal models are needed. In addition, our
data lack details about biomechanical properties and the contents
of collagen and proteoglycans in the regenerated meniscus. Also, it
is uncertain whether the regenerated menisci will prevent
secondary osteoarthritic change in the long term. Therefore, further
studies should be carried out.
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